Opportunity

Simpler Grants.gov #RFA-AI-27-016

NIH Tuberculosis Research Advancement Centers (TRACs) Grant Opportunity

Buyer

National Institutes of Health

Posted

December 16, 2025

Respond By

June 02, 2026

Identifier

RFA-AI-27-016

NAICS

541715

This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), aims to advance tuberculosis (TB) research through the Tuberculosis Research Advancement Centers (TRACs). - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Products/Services Requested: - Scientific leadership and administrative support for TB research - Mentoring and training for early career investigators and those new to TB research - Short-term funding for TB-specific pilot awards - Facilitation of high-impact collaborative studies among TRACs - Resources and training for basic and clinical TB research - Eligible Applicants: - Government agencies, educational institutions, nonprofits, businesses, and tribal organizations - Unique Requirements: - Only one application per institution (identified by UEI or NIH IPF number) - Additional eligibility requirements to be specified in the final Notice of Funding Opportunity (NOFO) - No specific OEMs or vendors are mentioned, as this is a research grant opportunity.

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support of the Tuberculosis (TB) Research Advancement Centers (TRACs). TRACs provide scientific leadership and administrative support to mentor or train early career investigators and those new to TB research. The initiative offers short term funding for TB-specific pilot awards and high impact collaborative studies with other TRACs, as well as resources and training for basic and clinical research. Grant authorities include Sections 301 and 405 of the Public Health Service Act and Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

View original listing